Losartan vs atenolol in prevention of stroke and cardiovascular disease

JAMA. 2003 Feb 12;289(6):700-1; author reply 701. doi: 10.1001/jama.289.6.700-b.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use*
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
  • Antihypertensive Agents / therapeutic use*
  • Atenolol / therapeutic use*
  • Cardiovascular Diseases / epidemiology*
  • Humans
  • Hypertension / drug therapy*
  • Losartan / therapeutic use*
  • Stroke / epidemiology*

Substances

  • Adrenergic beta-Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Antihypertensive Agents
  • Atenolol
  • Losartan